EYENOVIA, INC. (22)
- Business Finance (6)
- Human Resources (9)
- Intellectual Property (3)
- Uncategorized (4)
- Description of Securities (Filed With SEC on March 30, 2021)
- Amendment to Executive Employment Agreement, dated February 1, 2021, by and between the Company and Michael M. Rowe (Filed With SEC on February 3, 2021)
- License Agreement by and between Eyenovia, Inc. and Bausch Health Ireland Limited, dated October 9, 2020 (Filed With SEC on October 13, 2020)
- Underwriting Agreement, dated August 19, 2020, by and between Eyenovia, Inc. and William Blair & Company, L.L.C. as representative of the several underwriters named therein (Filed With SEC on August 21, 2020)
- License Agreement by and between Eyenovia, Inc. and Artic Vision (Hong Kong) Limited, dated August 10, 2020 (Filed With SEC on August 14, 2020)
- Letter Agreement by and between Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd., dated August 10, 2020 (Filed With SEC on August 14, 2020)
- Amendment to the Exclusive License Agreement by and between Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd., dated April 8, 2020 (Filed With SEC on August 14, 2020)
- Eyenovia, Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan (Filed With SEC on July 2, 2020)
- Promissory Note and Agreement dated May 3, 2020 (Filed With SEC on May 8, 2020)
- Description of Securities (Filed With SEC on March 30, 2020)
- Registration Rights Agreement, dated March 23, 2020, between Eyenovia, Inc. and the investors named therein (Filed With SEC on March 25, 2020)
- Securities Purchase Agreement, dated March 23, 2020, between Eyenovia, Inc. and the investors named therein (Filed With SEC on March 25, 2020)
- Form of Class B Warrant issued on March 24, 2020 (Filed With SEC on March 25, 2020)
- Form of Class A Warrant issued on March 24, 2020 (Filed With SEC on March 25, 2020)
- Underwriting Agreement, dated July 11, 2019, by and among Eyenovia, Inc. and Oppenheimer & Co. Inc., as representative of the several underwriters named therein (Filed With SEC on July 15, 2019)
- Eyenovia, Inc. 2018 Omnibus Stock Incentive Plan, as amended (Filed With SEC on June 12, 2019)
- Executive Employment Agreement, dated February 15, 2019, by and between the Company and John Gandolfo (Filed With SEC on February 19, 2019)
- Form of Nondisclosure, Assignment of Inventions and Noncompetition Agreement (Filed With SEC on February 19, 2019)
- Executive Employment Agreement, dated February 15, 2019, by and between the Company and Jennifer Clasby (Filed With SEC on February 19, 2019)
- Executive Employment Agreement, dated February 15, 2019, by and between the Company and Michael Rowe (Filed With SEC on February 19, 2019)
- Executive Employment Agreement, dated February 15, 2019, by and between the Company and Luke Clauson (Filed With SEC on February 19, 2019)
- Executive Employment Agreement, dated February 15, 2019, by and between the Company and Tsontcho Ianchulev (Filed With SEC on February 19, 2019)
